CXCL9, a promising biomarker in the diagnosis of chronic Q fever.

BMC Infect Dis 2017 08 9;17(1):556. Epub 2017 Aug 9.

Department of Internal Medicine 463, Radboud center for Infectious Diseases (RCI), Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

Background: In the aftermath of the largest Q fever outbreak in the world, diagnosing the potentially lethal complication chronic Q fever remains challenging. PCR, Coxiella burnetii IgG phase I antibodies, CRP and F-FDG-PET/CT scan are used for diagnosis and monitoring in clinical practice. We aimed to identify and test biomarkers in order to improve discriminative power of the diagnostic tests and monitoring of chronic Q fever.

Methods: We performed a transcriptome analysis on C. burnetii stimulated PBMCs of 4 healthy controls and 6 chronic Q fever patients and identified genes that were most differentially expressed. The gene products were determined using Luminex technology in whole blood samples stimulated with heat-killed C. burnetii and serum samples from chronic Q fever patients and control subjects.

Results: Gene expression of the chemokines CXCL9, CXCL10, CXCL11 and CCL8 was strongly up-regulated in C. burnetii stimulated PBMCs of chronic Q fever patients, in contrast to healthy controls. In whole blood cultures of chronic Q fever patients, production of all four chemokines was increased upon C. burnetii stimulation, but also healthy controls and past Q fever individuals showed increased production of CXCL9, CXCL10 and CCL8. However, CXCL9 and CXCL11 production was significantly higher for chronic Q fever patients compared to past Q fever individuals. In addition, CXCL9 serum concentrations in chronic Q fever patients were higher than in past Q fever individuals.

Conclusion: CXCL9 protein, measured in serum or as C. burnetii stimulated production, is a promising biomarker for the diagnosis of chronic Q fever.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-017-2656-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551022PMC
August 2017
46 Reads

Publication Analysis

Top Keywords

chronic fever
36
fever patients
24
fever
13
healthy controls
12
burnetii stimulated
12
chronic
10
promising biomarker
8
cxcl9 cxcl10
8
fever individuals
8
stimulated pbmcs
8
diagnosis chronic
8
biomarker diagnosis
8
cxcl9
6
patients
6
burnetii
6
expressed gene
4
controls fever
4
gene products
4
stimulation healthy
4
differentially expressed
4

References

(Supplied by CrossRef)

MC Wegdam-Blans et al.
Eur J Vasc Endovasc Surg 2011

M Million et al.
Lancet Infect Dis 2010

PP Broos et al.
J Vasc Surg 2015

MC Wegdam-Blans et al.
J Inf Secur 2012

V Merhej et al.
Comp Immunol Microbiol Infect Dis 2012

DG Barten et al.
BMC Infect Dis 2013

LM Kampschreur et al.
Clin Vaccine Immunol 2012

MC Wegdam-Blans et al.
Eur J Clin Microbiol Infect Dis 2014

T Schoffelen et al.
J Infect Dis 2015

M Oosting et al.
J Infect Dis 2010

A Ben Amara et al.
PLoS One 2010

Similar Publications